GKV Capital Management’s Idexx Laboratories IDXX Stock Holding History

GKV Capital Management’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.4M	Sell	2,650 -300	-10%	-$168K	0.45%	49
2026 Q1	$1.66M	Hold	2,950	–	–	0.62%	46
2025 Q4	$2M	Hold	2,950	–	–	0.75%	38
2025 Q3	$1.88M	Hold	2,950	–	–	0.74%	33
2025 Q2	$1.58M	Sell	2,950 -550	-16%	-$263K	0.7%	40
2025 Q1	$1.47M	Sell	3,500 -300	-8%	-$130K	0.73%	36
2024 Q4	$1.57M	Buy	+3,800	New	+$1.67M	0.64%	41

Other funds holding IDXX

MBI

Montrusco Bolton Investments Montreal, Quebec, Canada $6.46B AUM 26.7% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

CGI

Comgest Global Investors Paris, France $4.55B AUM 11.62% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Vontobel Holding Zurich, Switzerland $31.4B AUM 31.97% 1-Year Est. Return

CAM

Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Welch & Forbes Boston, Massachusetts $8.23B AUM 17.62% 1-Year Est. Return

GKV Capital Management's IDXX Position: Q2 2026 in Review

GKV Capital Management reduced its Idexx Laboratories (IDXX) stake by 10% in Q2 2026, selling an estimated $168K and leaving 2,650 shares worth $1.4M. The position accounts for 0.45% of the portfolio, ranked #49.

GKV Capital Management first reported a position in IDXX in Q4 2024 and has held it in 7 quarters since. The position peaked at $2M in Q4 2025. 545 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

GKV Capital Management held 2,650 shares of Idexx Laboratories worth $1.4M as of Q2 2026.
GKV Capital Management sold 300 Idexx Laboratories shares in Q2 2026, an estimated $168K.
Idexx Laboratories made up 0.45% of GKV Capital Management's portfolio in Q2 2026, its #49 holding.
GKV Capital Management first reported a position in Idexx Laboratories in Q4 2024 and has held it in 7 quarters since.
GKV Capital Management's Idexx Laboratories position peaked at $2M in Q4 2025.
545 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on GKV Capital Management's 13F filing for Q2 2026, filed 23 Jul 2026.